Renata Sano
St. Jude Children's Research Hospital
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Renata Sano.
Molecular Cell | 2009
Renata Sano; Ida Annunziata; Annette Patterson; Simon Moshiach; Elida Gomero; Joseph T. Opferman; Michael Forte; Alessandra d'Azzo
Mitochondria-associated ER membranes, or MAMs, define the sites of endoplasmic reticulum/mitochondria juxtaposition that control Ca(2+) flux between these organelles. We found that in a mouse model of the human lysosomal storage disease GM1-gangliosidosis, GM1-ganglioside accumulates in the glycosphingolipid-enriched microdomain (GEM) fractions of MAMs, where it interacts with the phosphorylated form of IP3 receptor-1, influencing the activity of this channel. Ca(2+) depleted from the ER is then taken up by the mitochondria, leading to Ca(2+) overload in this organelle. The latter induces mitochondrial membrane permeabilization (MMP), opening of the permeability transition pore, and activation of the mitochondrial apoptotic pathway. This study identifies the GEMs as the sites of Ca(2+) diffusion between the ER and the mitochondria. We propose a new mechanism of Ca(2+)-mediated apoptotic signaling whereby GM1 accumulation at the GEMs alters Ca(2+) dynamics and acts as a molecular effector of both ER stress-induced and mitochondria-mediated apoptosis of neuronal cells.
Genetics and Molecular Biology | 2011
Cléia Rosani Baiotto; Fernanda Sperb; Ursula da Silveira Matte; Claudia Dornelles da Silva; Renata Sano; Janice Carneiro Coelho; Roberto Giugliani
Infantile GM1 gangliosidosis is caused by the absence or reduction of lysosomal beta-galactosidase activity. Studies conducted in Brazil have indicated that it is one of the most frequent lysosomal storage disorders in the southern part of the country. To assess the incidence of this disorder, 390 blood donors were tested for the presence of two common mutations (1622–1627insG and R59H) in the GLB1 gene. Another group, consisting of 26 GM1 patients, and the blood donors were tested for the presence of two polymorphisms (R521C and S532G), in an attempt to elucidate whether there is a founder effect. The frequencies of the R59H and 1622–1627insG mutations among the GM1 patients studied were 19.2% and 38.5%, respectively. The frequency of polymorphism S532G was 16.7%, whereas R521C was not found in the patients. The overall frequency of either R59H or 1622–1627insG was 57.7% of the disease-causing alleles. This epidemiological study suggested a carrier frequency of 1:58. Seven different haplotypes were found. The 1622–1627insG mutation was not found to be linked to any polymorphism, whereas linkage disequilibrium was found for haplotype 2 (R59H, S532G) (p < 0.001). These data confirm the high incidence of GM1 gangliosidosis and the high frequency of two common mutations in southern Brazil.
Molecular Cell | 2004
Alessandra Tessitore; Maria del Pilar Martin; Renata Sano; Yanjun Ma; Linda Mann; Angela Ingrassia; Eric D. Laywell; Dennis A. Steindler; Linda M. Hendershot; Alessandra d'Azzo
Clinica Chimica Acta | 2005
Renata Sano; Vera Maria Treis Trindade; Alessandra Tessitore; Alessandra d'Azzo; Matheus Barbosa Vieira; Roberto Giugliani; Janice Carneiro Coelho
Archive | 2013
Renata Sano; Alessandra Tessitore; Angela Ingrassia; Alessandra d'Azzo; Memphis Tn
Molecular Genetics and Metabolism | 2009
Ida Annunziata; Renata Sano; Annette Patterson; Alessandra d’Azzo
Archive | 2005
Raquel Cristina Balestrin; Ursula da Silveira Matte; Matheus Barbosa Vieira; Renata Sano; Janice Carneiro Coelho; Roberto Giugliani
Archive | 2004
Raquel Cristina Balestrin; Matheus Barbosa Vieira; Roberto Giugliani; Renata Sano; Janice Carneiro Coelho; Alessandra d'Azzo; Ursula da Silveira Matte
Molecular Therapy | 2004
Renata Sano; Alessandra Tessitore; Angela Ingrassia; Alessandra d'Azzo
Archive | 2003
Matheus Barbosa Vieira; Renata Sano; Vera Maria Treis Trindade